Once again, the U.S. House Rules Committee has blocked a vote on a cannabis amendment. This time, the proposed measure would have encouraged the Department of Veterans Affairs (VA) to study the medical benefits of marijuana for military veterans.
The proposal, which Congressman Jared Polis (D-CO) was seeking to attach to the Stop the Importation and Trafficking of Synthetic Analogues Act, a bill dealing with synthetic drugs, would have required the VA to regularly report to Congress about the status of its cannabis research efforts.
Polis also unsuccessfully tried to move an amendment to prevent federal authorities from restricting the use of kratom, a plant that some people use for pain relief.
“The opioid epidemic has affected so many in the U.S., if not directly, indirectly through friends and family. Along with improving access to mental health services, drug abuse treatment, and prevention programs, we need to improve access to alternative pain relief options that work,” Polis said in a press release. “For some, kratom, a cousin of the coffee plant, can be such an alternative. For others, including many veterans, medical marijuana can help manage pain without resorting to more dangerous and addictive prescription opioids. Kratom and medical marijuana should be legal and available to our veterans.”
Under Chairman Pete Sessions (R-TX), the Rules Committee has made a practice over the past several years of blocking marijuana amendments from reaching the House floor.
This time was no different. On a party-line vote of 7 to 4 on Tuesday, the panel blocked the marijuana research amendment from having a chance to be considered on the House floor.
On Wednesday morning, Polis took to the floor to voice his disappointment about his amendments being blocked.
“Many states have medical marijuana available to patients with a variety of health issues, including chronic pain. Doctors across the country have prescribed medical marijuana as a legitimate treatment option for pain management,” he said. “In cases where it works, it provides a less harmful alternative, a less harmful and less addictive alternative to opioids.”
“I’ve heard from so many Coloradans for whom medical marijuana works instead of having to resort to opioids.”
“Unfortunately, medical marijuana is still illegal at the federal level,” Polis said. “There’s limited research opportunities about the safety and efficacy of marijuana, and that’s holding us back from really understanding how medical marijuana can be used for pain management. I offered a very simple and commonsense amendment at the Rules Committee last night that authorized the secretary of Veterans Affairs to study medical marijuana as an alternative treatment option to prescription opioids.”
Polis, who is a member of the Rules Committee, had some choice words for his Republican colleagues who control the panel:
“This bill is being considered under a closed rule. This is the 86th closed rule of this Congress. What that means, Mr. Chairman, not a single member, Democrat or Republican was able to offer an amendment to this bill… And there were good ideas on both sides that weren’t allowed to be advanced. The Republicans continue to bring bills to the floor this way to limit the opportunity for Republicans and Democrats to do something to stop opioid abuse. As a legislator who has a lot of ideas to save lives, increase freedom and decrease opioid abuse that would pass, I think a lot of my ideas would get 350 votes here in the House. We are not allowed to bring them forward. It is just so frustrating when we all know the human face of people that are suffering from being caught in a vicious cycle of opioid addiction and we have seen in our friends and family.”
The overall synthetic drugs bill is expected to receive a House floor vote on Friday.
AMENDMENT TO RULES COMMITTEE PRINT 115–74
OFFERED BY MR. POLIS OF COLORADO
At the end of the bill, insert the following:
SEC. 12. CONDUCT OF RESEARCH INTO EFFECTS OF CANNABIS ON HEALTH OUTCOMES OF CERTAIN VETERANS.
(a) RESEARCH.—In carrying out the responsibilities of the Secretary of Veterans Affairs under section 7303 of title 38, United States Code, the Secretary may conduct and support research relating to the efficacy and safety of medical cannabis on the health outcomes of covered veterans diagnosed with chronic pain, post-traumatic stress disorder, and other conditions the Secretary determines appropriate. The Secretary shall ensure that such research is conducted in accordance with applicable regulations relating to the oversight of research, including such regulations prescribed by the Office of Research and Development of the Department of Veterans Affairs, the Department of Health and Human Services (including through the National Institute on Drug Abuse), the Food and Drug Administration, the Drug Enforcement Administration, and the National Institutes of Health.
(b) DATA PRESERVATION.—Research conducted pursuant to subsection (a) shall include a mechanism to en3 sure the preservation of all data, including all data sets, collected or used for purposes of the research required by subsection (a) in a manner that will facilitate further research.
(c) REPORTS.—During the five-year period beginning on the date of the enactment of this Act, the Secretary shall submit periodically, but not less frequently than annually, to the Committees on Veterans’ Affairs of the House of Representatives and the Senate reports on—
(1) the implementation of this section; or
(2) the rationale of the Secretary with respect to determining not to implement this section.
(d) COVERED VETERAN DEFINED.—In this section, the term ‘‘covered veteran’’ means a veteran who is enrolled in the patient enrollment system of the Department of Veterans Affairs under section 1705 of title 38, United States Code.
Mexican Government Officials Visit Canada To Learn About Marijuana Legalization
The office of Mexican President-elect Andrés Manuel López Obrador announced on Friday that key members of his incoming cabinet will discuss marijuana legalization with Canadian government officials on a visit to the country next week.
As part of the trip by seven secretaries-designate, officials from the two nations will meet about issues such as human rights, inclusive governance and “regulation of cannabis use,” a press release from López Obrador’s transition team said.
Among those taking the trip north will be Olga Sánchez Cordero, the likely next interior secretary of Mexico, who has previously said she would encourage the new president to legalize marijuana and pursue broader drug policy reforms.
Canada’s marijuana legalization law went into effect this week.
López Obrador will be sworn in as president on December 1.
Canadian Lawmaker Vapes Marijuana And Doesn’t Care What Anyone Thinks
A Canadian member of Parliament openly consumes marijuana, something he says will be completely normal and not at all noteworthy soon in light of the country’s new legalization law that went into effect this week.
“Just as someone might have a glass of wine or a scotch on a Friday night, I would turn to my vaporizer,” MP Nathaniel Erskine-Smith said in an interview with CBC news.
But it’s not all about getting high for fun and relaxation for the member of Liberal Prime Minister Justin Trudeau’s party. He also consumes cannabis medicinally.
“I have Crohn’s, so sometimes I turn to it for that reason as well,” he said.
Within a matter of years, though, no one will care whether lawmakers toke up, Erskine-Smith believes.
“Five years from now, no one will be interested in this question because we’ll all recognize we’re responsible adults, and this is far less harmful than alcohol, far less harmful than tobacco,” he said. “And we should use it responsibly, yes, because there are potential harms.”
“Certainly Canadians are capable of doing this because we’ve been doing it for decades.”
On that point, Erskine-Smith acknowledged that he too has been consuming cannabis before prohibition officially lifted on Wednesday.
“It would be sort of silly for me to stop now, wouldn’t it?” he asked.
MP Nathaniel Erskine-Smith says he enjoys cannabis, and that five years from now, no one will care to ask him about it. pic.twitter.com/L7U3N46EwW
— CBC News: The National (@CBCTheNational) October 18, 2018
Photo courtesy of Cannabis Culture.
Missouri Campaign Finance Records Show Medical Marijuana Ballot Battle Heating Up
New quarterly campaign finance documents from Missouri medical marijuana ballot committees, covering activity from July 1 to September 30, show some coalescing of support for one of three measures on the ballot, while a recently created committee that opposes all of the medical cannabis options has yet to report any financial support.
Here’s what the fundraising and expenditures for the key committees behind each of the three proposed measures look like:
(Note: only those committees with major activity in Q3 are displayed)
Missouri has one of the most confusing sets of marijuana ballot options to ever go before voters in any state, with two proposed constitutional amendments and one proposed statutory measure to choose from. Each option was sponsored by a separate committee that actively attacked the others in the months leading up to qualifying this summer to get on the ballot, with hostile campaign tactics continuing since then—including lawsuits and opposition research into the personal finances of advocates.
In the last few months, two additional organizations entered the fray. One is the only ballot committee that opposes both of the amendments and the proposition. Citizens for SAFE Medicine registered on September 20, and did not report any financial contributions or expenditures on its October 15 report. Judy Brooks, listed as Treasurer of the organization, is also a founder of Jefferson City’s Council For Drug Free Youth.
The other is “Patients Against Bradshaw Amendment Formally Known As Find The Cures Political Action Committee.” The committee, which registered August 27, opposes Amendment 3 and supports Amendment 2. It raised $1,441 cash from five donors, and has spent $447 of that on campaigning.
Its verbose name is a reference to Dr. Brad Bradshaw, the main financial contributor to Find the Cures, a committee that registered in September 2015 to support the measure now designated as Amendment 3. Between October 2017 and June 2018, he provided loans to Find the Cures to the tune of $1.2 million. The committee spent over $800,000 of that to hire a signature collection firm to get on the ballot.
Bradshaw’s measure would, among other things, create a research center that many suspect he intends to run himself. It had already come under fire from Missouri NORML, which backs New Approach Missouri and its preferred proposal, Amendment 2. Find the Cures had already raised $1,556,705 in the first half of 2018 (much of that in the loans from Bradshaw), but started the most recent quarter with just $79 in the bank. From July through September, the committee took in another $209,111, with $186,121 of that in the form of additional loans from Bradshaw. It spent $164,739 on advertising and campaign staff, leaving $44,451 cash on hand for the remaining weeks before the election.
Under Amendment 2, doctors would be allowed to recommend medical cannabis for any condition they feel it is needed. Registered patients and caregivers would be permitted to grow up to six marijuana plants and purchase up to four ounces from dispensaries per month. Medical cannabis sales at dispensaries would be taxed at four percent. As previously reported by Marijuana Moment, the St. Louis chapter of the NAACP, Freedom Incorporated and the St. Louis American newspaper support Amendment 2. It also recently garnered an endorsement from the St. Louis Post-Dispatch.
New Approach Missouri was the most active committee in terms of continuing to raise and spend funds in quarter three of 2018. The group, which had already raised $1,057,263 for the election, took in another $256,924 cash and $15,368 worth of in-kind contributions. They spent $229,122 in the quarter, for events, legal fees, database management, media creation and public affairs in support of Amendment 2. One employee has been paid a total of $116,180 over the course of the campaign. They had $39,878 in the bank at the end of September.
Long-time political action committee Show-Me Cannabis Regulation, which has been around for seven years, had little activity last quarter, bringing in $350 and spending $72, leaving $2,250 on hand. It has however seemingly thrown its support behind New Approach Missouri, providing $5,000 in in-kind support to the committee.
Here’s a chart using a logarithmic scale that includes more of the committees, even those with relatively paltry finances:
(Note: scale is logarithmic in order to depict smaller committees)
Missourians for Patient Care, which supports Proposition C, had little money activity in the most recent reporting period, suggesting that it is perhaps stepping back from active campaigning at this point. The group had raised a whopping $1,393,360 in 2018, but had only $31,077 left on hand at the beginning of July. In the last three months, it brought in $115 and reported no expenses.
One additional committee that formed, “Missouri Medical Marijuana,” that supported “medical marijuana measure,” has terminated its operations.
On Election Day, we will see whether the millions of dollars spent result in Missouri voters enacting one of more of the cannabis ballot proposals.